United States · 
Who invested in Arkuda Therapeutics?
Arkuda Therapeutics's investors include Atlas Venture, Cormorant Asset Management, Eli Lilly and Mission BioCapital.
United States · Series B startup
Who invested in Arkuda Therapeutics
Funding summaryUpdated 26 Oct 2026
$64Mraised across 1 round since 2022, from 1 source
- Latest round
- Series B, $64MFeb 2022
- Investors
- 4
The rounds
- Feb 2022
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Arkuda Therapeutics
How much has Arkuda Therapeutics raised?
Arkuda Therapeutics has raised $64M across 1 round since 2022.
When did Arkuda Therapeutics last raise?
Arkuda Therapeutics's most recent round was a Series B of $64M in Feb 2022.
What was Arkuda Therapeutics's biggest round?
Its most recent round, $64M in Feb 2022, is also its largest on record.
Who backed Arkuda Therapeutics first?
Arkuda Therapeutics's first round on record, in Feb 2022, was backed by Atlas Venture, Cormorant Asset Management and Eli Lilly and 1 others.
What stage is Arkuda Therapeutics at?
Arkuda Therapeutics's latest named round is a Series B, in Feb 2022.
Where is Arkuda Therapeutics based?
Arkuda Therapeutics is based in the United States.
Companies like Arkuda Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.